The trial was a complete success. Every dog was alive months later, including the dog who was disqualified from the trial because it had to be given an anti-inflamatory. Given the death rate of naive b cell lymphoma, they got the results they wanted, nothing less. Now if you're going to tell me that after that, Elanco gave up at that point just because the sample was too small, then I can only say that I think you're barking up the wrong tree.
Good night
copy of PAA AGM questions and answers, page-99
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $66.44K | 346.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 86359 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 107894 | 5 |
View Market Depth
| Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |